P-Glycoprotein Deficiency in a Subpopulation of CF-1 Mice Enhances Avermectin-Induced Neurotoxicity
- 1 April 1997
- journal article
- research article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 143 (2), 357-365
- https://doi.org/10.1006/taap.1996.8086
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Ivermectin for spasticity in spinal-cord injuryThe Lancet, 1994
- Structure and expression of the human MDR (P-glycoprotein) gene family.Molecular and Cellular Biology, 1989
- THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCEAnnual Review of Biochemistry, 1989
- The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues.Molecular and Cellular Biology, 1989
- Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.Proceedings of the National Academy of Sciences, 1989
- Simultaneous expression of two P-glycoprotein genes in drug-sensitive Chinese hamster ovary cells.Molecular and Cellular Biology, 1987
- P-glycoprotein in human sarcoma: evidence for multidrug resistance.Journal of Clinical Oncology, 1987
- The cell biology of multiple drug resistanceBiochemical Pharmacology, 1987
- Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cellsCell, 1986
- Avermectins. Structure determinationJournal of the American Chemical Society, 1981